Published on 22 Apr 2024 on Zacks via Yahoo Finance
Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this world's biggest maker of health care products have returned -4.7%, compared to the Zacks S&P 500 composite's -4% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which Johnson & Johnson falls in, has lost 4.2%. The key question now is: What could be the stock's future direction?